Stay updated on ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial

Sign up to get notified when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a Study Results entry and a Publications note indicating publications are provided voluntarily by the submitter. Removed General/IPD-sharing related entries.
    Difference
    0.5%
    Check dated 2026-04-09T08:12:25.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision notes updated: added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-25T20:41:46.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T16:39:39.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed outdated notices (including the lapse in government funding notice and Revision: v3.4.1), reflecting minor site maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T01:56:18.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with NIH Clinical Center status and updated the page version to Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T23:16:39.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Additions include Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0; Deletions include Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. These are minor UI/metadata changes and do not alter core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T20:17:53.000Z thumbnail image

Stay in the know with updates to ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.